πŸ‡ΊπŸ‡Έ FDA
Patent

US 11602567

Methods for modulating RNA splicing

granted A61KA61K31/519A61K31/711

Quick answer

US patent 11602567 (Methods for modulating RNA splicing) held by PTC THERAPEUTICS, INC. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/519, A61K31/711, A61K48/0025